Current FDA-approved therapies include clot-busting medications (t-PA) that can be administered intravenously (through a needle in the arm) within three hours, and sometimes up to 4.5 hrs, of symptom onset, as well as certain devices that can break up or remove the clot when applied within six hours of symptom onset.